Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Stroke. 2017 Jan 19;48(3):802–804. doi: 10.1161/STROKEAHA.116.015779

Table 1.

Race/ethnicity and levetiracetam use were associated (P=0.0000008) in the multi-center cohort.

Race No Levetiracetam (N=2386) Levetiracetam (N=748)
1 Native American 12 (1) 4 (1)
2 Asian 81 (3) 23(3)
3 Black 1041 (44) 239 (32)
4 Hispanic or Latino 78 (3) 16 (2)
5 Pacific Islander 5 (0) 6 (0)
6 White 1051 (44) 413 (56)
7 Declined 51 (2) 23 (3)
8 Other 67 (3) 24(3)

Data are N(%). Data do not sum to 3,422 due to missing data in some patients on race/ethnicity.